Press Room

Hovione is the first Chemical/Pharmaceutical Company integrating this innovative community of companies that use the power of business to solve social and environmental problems. As a Certified B Corporation Hovione wants to contribute to redefine success in business, meeting the highest standards of social and environmental performance, setting its team members for success and personal satisfaction and aspiring to use the power of markets to solve social and environmental problems. Hovione believe that B Corps, and especially those that are family businesses, through the power of their collective voice, are competing to be Best for the World® and through them society will enjoy a more shared and durable prosperity. To certify as a B Corp, a set of rigorous social and environmental standards must be met. This is achieved through the B Impact Assessment process that requires four principle areas to be assessed: governance model, workers, environment protection and community involvement, including the impact on its suppliers. Hovione's certification process began almost a year ago. During this period B Lab assessed Hovione's policies and procedures in all locations with its operations around the world (Portugal, Ireland, United States and Asia). They concluded that Hovione follows all the appropriate models and can thus be part of this movement. This is a global movement of people using business as a force for goodTM with a vision that one day all companies compete not only to be the best in the world, but the Best for the World®.    

News

Hovione receives B Corp Certification

Jun 22, 2017

Paul joined Hovione on the 1st of October 2014. He holds a BSc in Chemical and Pharmaceutical Science from the University of Sunderland (UK) and a PhD in Organic Chemistry (asymmetric synthesis using organometallics) from Sheffield University (UK). He started his industrial career with Fisons Pharmaceuticals in Loughborough, where he worked in the R&D Analytical Laboratory. In early 1997, Paul joined Ciba-Geigy in Grimsby as a Process Chemist in the Chemical Operations area (Ciba-Geigy merged with Sandoz at that time and became Novartis later in 1997). He subsequently held several senior lead roles in both Quality and Production with Novartis. In 2007 he moved to New York to head up the Operations Unit  for Pharmaceutical Operations. As a result of Paul’s success in this function he was asked, in 2009, to take on the role of Global Head of Pharmaceutical Operations Strategy for Technical Operations at Head Office in Basel, where he stayed until 2012. Paul then chose to return to Cork with his family  and was invited by Chanelle Group to become Director of Operations near Galway. Paul brings to Hovione over 20 years of relevant experience of development, quality, APIs manufacturing and formulation, as well as pharma strategy with Novartis and Chanelle. He also has considerable expertise in operational efficiency and world-class team leadership in pharma operations.   Hovione Cork - click here  

News

Hovione Cork – New General Manager - Paul Downing – since 1st October 2014

Oct 01, 2014

Contact Us

If you would like to learn more about Hovione, kindly fill in the form below and we will be revert to you soon.